Cargando…
Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
BACKGROUND: Nonalcoholic fatty liver disease is characterized by excessive hepatic fat accumulation. Some individuals frequently present elevated gamma-glutamyl transferase (GGT) levels without fatty liver ultrasound images and other abnormal liver enzymes levels. However, whether these individuals...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350574/ https://www.ncbi.nlm.nih.gov/pubmed/32650722 http://dx.doi.org/10.1186/s12876-020-01369-x |
_version_ | 1783557294685945856 |
---|---|
author | Fujii, Hideki Doi, Haruna Ko, Tetsuhisa Fukuma, Taito Kadono, Toru Asaeda, Kohei Kobayashi, Reo Nakano, Takahiro Doi, Toshifumi Nakatsugawa, Yoshikazu Yamada, Shinya Nishimura, Takeshi Tomatsuri, Naoya Sato, Hideki Okuyama, Yusuke Kimura, Hiroyuki Kishimoto, Etsuko Nakabe, Nami Shima, Takatomo |
author_facet | Fujii, Hideki Doi, Haruna Ko, Tetsuhisa Fukuma, Taito Kadono, Toru Asaeda, Kohei Kobayashi, Reo Nakano, Takahiro Doi, Toshifumi Nakatsugawa, Yoshikazu Yamada, Shinya Nishimura, Takeshi Tomatsuri, Naoya Sato, Hideki Okuyama, Yusuke Kimura, Hiroyuki Kishimoto, Etsuko Nakabe, Nami Shima, Takatomo |
author_sort | Fujii, Hideki |
collection | PubMed |
description | BACKGROUND: Nonalcoholic fatty liver disease is characterized by excessive hepatic fat accumulation. Some individuals frequently present elevated gamma-glutamyl transferase (GGT) levels without fatty liver ultrasound images and other abnormal liver enzymes levels. However, whether these individuals are at an elevated risk for developing fatty liver is unclear. We compared fatty liver change rates and risk factors between individuals with frequently elevated GGT levels and those with normal levels. METHODS: We designed a retrospective cohort study on the basis of complete medical checkup records. One group of individuals had presented normal serum GGT levels during the observation period (Normal-GGT group, n = 2713). Another group had had abnormal elevated serum GGT levels frequently (Abnormal-GGT group, n = 264). We determined the fatty liver change incident rates before and after propensity score matching. We explored confounding factors affecting fatty changes in each group using univariate and multivariate Cox models. RESULTS: The change incidence rates were 5.80/1000 and 10.02/1000 person-years in the Normal-GGT and Abnormal-GGT groups, respectively. After propensity score matching, the incidence rates were 3.08/1000 and 10.18/1000 person-years in the Normal-GGT and Abnormal-GGT groups, respectively (p = 0.026). The factors associated with fatty liver changes in the Normal-GGT group included body mass index (BMI), hemoglobin, alanine aminotransferase (ALT), albumin, triglyceride (TG), fasting blood sugar, and high-density lipoprotein levels. Those in the Abnormal-GGT group were platelet counts and TG. In our multivariable analysis, BMI, ALT, albumin, and TG levels were independent predictors of fatty changes in the Normal-GGT group, and high TG level was the only independent predictor in the Abnormal-GGT group. CONCLUSIONS: The incidence rate of fatty liver change in the Abnormal-GGT group was higher than that in the Normal-GGT group. Consecutive elevated GGT levels increase the risk for fatty liver, and high TG levels in those individuals further independently increase the risk. |
format | Online Article Text |
id | pubmed-7350574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73505742020-07-14 Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study Fujii, Hideki Doi, Haruna Ko, Tetsuhisa Fukuma, Taito Kadono, Toru Asaeda, Kohei Kobayashi, Reo Nakano, Takahiro Doi, Toshifumi Nakatsugawa, Yoshikazu Yamada, Shinya Nishimura, Takeshi Tomatsuri, Naoya Sato, Hideki Okuyama, Yusuke Kimura, Hiroyuki Kishimoto, Etsuko Nakabe, Nami Shima, Takatomo BMC Gastroenterol Research Article BACKGROUND: Nonalcoholic fatty liver disease is characterized by excessive hepatic fat accumulation. Some individuals frequently present elevated gamma-glutamyl transferase (GGT) levels without fatty liver ultrasound images and other abnormal liver enzymes levels. However, whether these individuals are at an elevated risk for developing fatty liver is unclear. We compared fatty liver change rates and risk factors between individuals with frequently elevated GGT levels and those with normal levels. METHODS: We designed a retrospective cohort study on the basis of complete medical checkup records. One group of individuals had presented normal serum GGT levels during the observation period (Normal-GGT group, n = 2713). Another group had had abnormal elevated serum GGT levels frequently (Abnormal-GGT group, n = 264). We determined the fatty liver change incident rates before and after propensity score matching. We explored confounding factors affecting fatty changes in each group using univariate and multivariate Cox models. RESULTS: The change incidence rates were 5.80/1000 and 10.02/1000 person-years in the Normal-GGT and Abnormal-GGT groups, respectively. After propensity score matching, the incidence rates were 3.08/1000 and 10.18/1000 person-years in the Normal-GGT and Abnormal-GGT groups, respectively (p = 0.026). The factors associated with fatty liver changes in the Normal-GGT group included body mass index (BMI), hemoglobin, alanine aminotransferase (ALT), albumin, triglyceride (TG), fasting blood sugar, and high-density lipoprotein levels. Those in the Abnormal-GGT group were platelet counts and TG. In our multivariable analysis, BMI, ALT, albumin, and TG levels were independent predictors of fatty changes in the Normal-GGT group, and high TG level was the only independent predictor in the Abnormal-GGT group. CONCLUSIONS: The incidence rate of fatty liver change in the Abnormal-GGT group was higher than that in the Normal-GGT group. Consecutive elevated GGT levels increase the risk for fatty liver, and high TG levels in those individuals further independently increase the risk. BioMed Central 2020-07-10 /pmc/articles/PMC7350574/ /pubmed/32650722 http://dx.doi.org/10.1186/s12876-020-01369-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Fujii, Hideki Doi, Haruna Ko, Tetsuhisa Fukuma, Taito Kadono, Toru Asaeda, Kohei Kobayashi, Reo Nakano, Takahiro Doi, Toshifumi Nakatsugawa, Yoshikazu Yamada, Shinya Nishimura, Takeshi Tomatsuri, Naoya Sato, Hideki Okuyama, Yusuke Kimura, Hiroyuki Kishimoto, Etsuko Nakabe, Nami Shima, Takatomo Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study |
title | Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study |
title_full | Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study |
title_fullStr | Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study |
title_full_unstemmed | Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study |
title_short | Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study |
title_sort | frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350574/ https://www.ncbi.nlm.nih.gov/pubmed/32650722 http://dx.doi.org/10.1186/s12876-020-01369-x |
work_keys_str_mv | AT fujiihideki frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT doiharuna frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT kotetsuhisa frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT fukumataito frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT kadonotoru frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT asaedakohei frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT kobayashireo frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT nakanotakahiro frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT doitoshifumi frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT nakatsugawayoshikazu frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT yamadashinya frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT nishimuratakeshi frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT tomatsurinaoya frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT satohideki frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT okuyamayusuke frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT kimurahiroyuki frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT kishimotoetsuko frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT nakabenami frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy AT shimatakatomo frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy |